Showing results (611-620 of 629) with videos related to
Sort By:
Pageof 63
The American Journal of Gastroenterology|March 20, 2023
Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized TrialPing-I Hsu, Kuan-Yang Chen, Wei-Chen Tai, et al.Plos One|January 3, 2018
Association between Helicobacter pylori eradication and the risk of coronary heart diseasesJiunn-Wei Wang, Kuo-Lun Tseng, Chien-Ning Hsu, et al.Molecular Oncology|April 1, 2018
Serum amyloid A1 in combination with integrin αVβ3 increases glioblastoma cells mobility and progressionChing-Yu Lin, Shun-Tai Yang, Shing-Chuan Shen, et al.Toxicology and Applied Pharmacology|June 22, 2005
Biomarkers of exposure, effect, and susceptibility of arsenic-induced health hazards in TaiwanChien-Jen Chen, Lin-I Hsu, Chih-Hao Wang, et al.World Journal of Gastroenterology|November 3, 2025
Sequential changes of antibiotic resistances of <i>Helicobacter pylori</i> in Taiwan from 2019 to 2024Pei-Jui Wu, Feng-Woei Tsay, Deng-Chyang Wu, et al.Elife|June 19, 2024
<i>SOD1</i> is a synthetic-lethal target in <i>PPM1D</i>-mutant leukemia cellsLinda Zhang, Joanne I Hsu, Etienne D Braekeleer, et al.Biorxiv : the Preprint Server for Biology|September 11, 2023
<i>SOD1</i> is a synthetic lethal target in <i>PPM1D</i>-mutant leukemia cellsLinda Zhang, Joanne I Hsu, Etienne D Braekeleer, et al.Blood Advances|March 6, 2025
DNMT3A regulates murine megakaryocyte-biased hematopoietic stem cell fate decisionsSarah M Waldvogel, Virginia Camacho, Dandan Fan, et al.Blood|May 5, 2022
Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasmsAdam S Sperling, Veronica A Guerra, James A Kennedy, et al.Biorxiv : the Preprint Server for Biology|May 15, 2024
Mimicking opioid analgesia in cortical pain circuitsJustin G James, Nora M McCall, Alex I Hsu, et al.Pageof 63